LSE - Delayed Quote GBp
BSF Enterprise Plc (BSFA.L)
1.2500
-0.1250
(-9.09%)
As of 1:53:53 PM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Che John Connon | CEO, MD & Executive Director | 130k | -- | 1972 |
| Mr. Geoffrey Robert Baker B.Com., L.L.B., M.B.A. | Company Secretary & Executive Director | 92k | -- | 1956 |
| Mr. Graham John William Duncan | Chief Financial Officer | -- | -- | 1963 |
| Mr. Ricardo Gouveia | C.S.O | -- | -- | -- |
| Mr. Marcelo Bravo | Chief Business Officer | -- | -- | -- |
BSF Enterprise Plc
2 Portman Street
London, W1H 6DU
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 15
Description
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.
Corporate Governance
BSF Enterprise Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available